Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iPROGRESS: 68Ga-DOTATATE PET-CTA for Coronary Atherosclerosis
NCT04043377Phase 3Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2019
- Primary completion
- Sep 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gallium ga 68 dotatate in Coronary atherosclerosis (CAD), sponsored by Assistance publique - Hôpitaux de Paris. Started Nov 2019; status: terminated.
02
Drugs
gallium ga 68 dotatate
03
Conditions
Coronary atherosclerosis (CAD)
Beyond the preview
Go deeper on NCT04043377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04043377.